Back to Search
LINDY WYATT, M.D., PHD
M.D., PHD
Neurology Physician
NPI: 1427006709Individual
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
35-072489(OH)
Research & Publications (20)
Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selection.
PMID 19420086·J Virol·2009
8-other
Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization.
PMID 19257896·Virol J·2009
7-preclinical
Preclinical studies of human immunodeficiency virus/AIDS vaccines: inverse correlation between avidity of anti-Env antibodies and peak postchallenge viremia.
PMID 19224993·J Virol·2009
7-preclinical
The teller acuity cards are effective in detecting amblyopia.
PMID 19390474·Optom Vis Sci·2009
4-observational
Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
PMID 18678911·Proc Natl Acad Sci U S A·2008
4-observational
Normative pediatric visual acuity using single surrounded HOTV optotypes on the Electronic Visual Acuity Tester following the Amblyopia Treatment Study protocol.
PMID 18155943·J AAPOS·2008
8-other
Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.
PMID 18048074·Virology·2008
7-preclinical
A conserved poxvirus NlpC/P60 superfamily protein contributes to vaccinia virus virulence in mice but not to replication in cell culture.
PMID 18281072·Virology·2008
7-preclinical
Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax.
PMID 17977963·J Virol·2008
4-observational
Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines.
PMID 18155813·Vaccine·2008
7-preclinical
Immunogenicity in macaques of the clinical product for a clade B DNA/MVA HIV vaccine: elicitation of IFN-gamma, IL-2, and TNF-alpha coproducing CD4 and CD8 T cells.
PMID 18160013·AIDS Res Hum Retroviruses·2007
7-preclinical
DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.
PMID 17507071·Virology·2007
7-preclinical
Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate.
PMID 17499326·Virology·2007
7-preclinical
The protein tyrosine phosphatase Pez regulates TGFbeta, epithelial-mesenchymal transition, and organ development.
PMID 17893246·J Cell Biol·2007
7-preclinical
Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost.
PMID 17360078·Vaccine·2007
7-preclinical
GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine.
PMID 17698160·Virology·2007
7-preclinical
T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cells.
PMID 17201662·Viral Immunol·2006
8-other
Nurse-led community approach to asthma management for children.
PMID 17175826·Aust Nurs J·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6406 THORNBERRY CT, SUITE 220B
MASON, OH 45040 - Phone
- (937) 672-4730
Quick Facts
- NPI
- 1427006709
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile